Howden C W, Jones D B, Peace K E, Burget D W, Hunt R H
Department of Materia Medica, Stobhill General Hospital, Glasgow, Scotland, U.K.
Dig Dis Sci. 1988 May;33(5):619-24. doi: 10.1007/BF01798367.
Published clinical trials (N = 56) of antisecretory drugs in the treatment of benign gastric ulcer were reviewed. Composite healing rates for various drug regimens were calculated using a method previously described for duodenal ulcer. Healing rates were compared with data on suppression of intragastric acidity to see if any relationship was evident. No significant correlations between the two existed, unless placebo data were included in the analysis. Correlations were stronger with suppression of total 24-hr rather than nocturnal acidity. Using Williams' method for assessing trends, it was found that an increase in antisecretory effect is not associated with a concomitant increase in healing rates. Duration of medical treatment is the single most important factor in healing of benign gastric ulcer; healing rates for all drug regimens and placebo show a consistent increase with prolongation of treatment.
对已发表的56项抗分泌药物治疗良性胃溃疡的临床试验进行了综述。采用先前描述的十二指肠溃疡方法计算了各种药物治疗方案的综合愈合率。将愈合率与胃内酸度抑制数据进行比较,以观察是否存在明显关系。除非分析中纳入安慰剂数据,否则两者之间不存在显著相关性。与24小时总酸度抑制的相关性比与夜间酸度抑制的相关性更强。使用威廉姆斯方法评估趋势,发现抗分泌作用的增加与愈合率的相应增加无关。药物治疗的持续时间是良性胃溃疡愈合的唯一最重要因素;所有药物治疗方案和安慰剂的愈合率均随着治疗时间的延长而持续增加。